CXCL1 and colorectal carcinoma: The study conducted by Kong et al. was the first to demonstrate that CXCL1 suppresses CD8+ T cell proliferation, cytotoxic activity, and chemotaxis, thereby facilitating immune evasion in CRC through autophagy-mediated degradation of MHC class I molecules [81].